108 related articles for article (PubMed ID: 16497147)
1. Kinin- and angiotensin-converting enzyme (ACE) inhibitor-mediated nitric oxide production in endothelial cells.
Skidgel RA; Stanisavljevic S; Erdös EG
Biol Chem; 2006 Feb; 387(2):159-65. PubMed ID: 16497147
[TBL] [Abstract][Full Text] [Related]
2. Kinin B1 receptors stimulate nitric oxide production in endothelial cells: signaling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands.
Ignjatovic T; Stanisavljevic S; Brovkovych V; Skidgel RA; Erdös EG
Mol Pharmacol; 2004 Nov; 66(5):1310-6. PubMed ID: 15304551
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin I-converting enzyme inhibitors block protein kinase C epsilon by activating bradykinin B1 receptors in human endothelial cells.
Stanisavljevic S; Ignjatovic T; Deddish PA; Brovkovych V; Zhang K; Erdös EG; Skidgel RA
J Pharmacol Exp Ther; 2006 Mar; 316(3):1153-8. PubMed ID: 16282523
[TBL] [Abstract][Full Text] [Related]
4. High glucose increases B1-kinin receptor expression and signaling in endothelial cells.
Rodriguez AI; Pereira-Flores K; Hernández-Salinas R; Boric MP; Velarde V
Biochem Biophys Res Commun; 2006 Jun; 345(2):652-9. PubMed ID: 16696940
[TBL] [Abstract][Full Text] [Related]
5. Lack of direct interaction between enalaprilat and the kinin B1 receptors.
Morissette G; Couture JP; Désormeaux A; Adam A; Marceau F
Peptides; 2008 Apr; 29(4):606-12. PubMed ID: 18201802
[TBL] [Abstract][Full Text] [Related]
6. Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus.
Couture R; Girolami JP
Eur J Pharmacol; 2004 Oct; 500(1-3):467-85. PubMed ID: 15464053
[TBL] [Abstract][Full Text] [Related]
7. B2-kinin receptor plays a key role in B1-, angiotensin converting enzyme inhibitor-, and vascular endothelial growth factor-stimulated in vitro angiogenesis in the hypoxic mouse heart.
Sanchez de Miguel L; Neysari S; Jakob S; Petrimpol M; Butz N; Banfi A; Zaugg CE; Humar R; Battegay EJ
Cardiovasc Res; 2008 Oct; 80(1):106-13. PubMed ID: 18566101
[TBL] [Abstract][Full Text] [Related]
8. Endothelial antioxidant actions of dihydropyridines and angiotensin converting enzyme inhibitors.
Rosenkranz AC; Lob H; Breitenbach T; Berkels R; Roesen R
Eur J Pharmacol; 2006 Jan; 529(1-3):55-62. PubMed ID: 16313901
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function.
Erdös EG; Tan F; Skidgel RA
Hypertension; 2010 Feb; 55(2):214-20. PubMed ID: 20065150
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor-2 mediates Angiotensin-converting enzyme inhibitor-induced angiogenesis in coronary endothelium.
Donnini S; Solito R; Giachetti A; Granger HJ; Ziche M; Morbidelli L
J Pharmacol Exp Ther; 2006 Nov; 319(2):515-22. PubMed ID: 16868034
[TBL] [Abstract][Full Text] [Related]
11. Effect of Panax ginseng extract (G115) on angiotensin-converting enzyme (ACE) activity and nitric oxide (NO) production.
Persson IA; Dong L; Persson K
J Ethnopharmacol; 2006 May; 105(3):321-5. PubMed ID: 16387458
[TBL] [Abstract][Full Text] [Related]
12. [ACE inhibitors--activators of kinin receptors].
Kugaevskaia EV; Eliseeva IuE
Biomed Khim; 2011; 57(3):282-99. PubMed ID: 21863742
[TBL] [Abstract][Full Text] [Related]
13. Tea flavanols inhibit angiotensin-converting enzyme activity and increase nitric oxide production in human endothelial cells.
Persson IA; Josefsson M; Persson K; Andersson RG
J Pharm Pharmacol; 2006 Aug; 58(8):1139-44. PubMed ID: 16872562
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme (ACE) inhibitors modulate cellular retinol-binding protein 1 and adiponectin expression in adipocytes via the ACE-dependent signaling cascade.
Kohlstedt K; Gershome C; Trouvain C; Hofmann WK; Fichtlscherer S; Fleming I
Mol Pharmacol; 2009 Mar; 75(3):685-92. PubMed ID: 19114589
[TBL] [Abstract][Full Text] [Related]
15. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
Mehta VB; Zhou Y; Radulescu A; Besner GE
Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
[TBL] [Abstract][Full Text] [Related]
16. Kinins, receptors, kininases and inhibitors--where did they lead us?
Erdös EG; Marcic BM
Biol Chem; 2001 Jan; 382(1):43-7. PubMed ID: 11258670
[TBL] [Abstract][Full Text] [Related]
17. A novel pathway for receptor-mediated post-translational activation of inducible nitric oxide synthase.
Brovkovych V; Zhang Y; Brovkovych S; Minshall RD; Skidgel RA
J Cell Mol Med; 2011 Feb; 15(2):258-69. PubMed ID: 20015194
[TBL] [Abstract][Full Text] [Related]
18. Carboxypeptidase M augments kinin B1 receptor signaling by conformational crosstalk and enhances endothelial nitric oxide output.
Zhang X; Tan F; Brovkovych V; Zhang Y; Lowry JL; Skidgel RA
Biol Chem; 2013 Mar; 394(3):335-45. PubMed ID: 23183746
[TBL] [Abstract][Full Text] [Related]
19. [Mechanisms of action of angiotensin I converting enzyme inhibitors].
Wiecek A
Przegl Lek; 1994; 51(4):193-7. PubMed ID: 8058992
[TBL] [Abstract][Full Text] [Related]
20. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells.
Batova S; DeWever J; Godfraind T; Balligand JL; Dessy C; Feron O
Cardiovasc Res; 2006 Aug; 71(3):478-85. PubMed ID: 16814758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
